Nutriband (OTCMKTS:NTRB) and Alpha Pro Tech (NYSE:APT) Financial Comparison - Defense World

2022-06-10 20:28:05 By : Ms. Sophie Pan

Posted by admin on Jun 5th, 2022

Nutriband (OTCMKTS:NTRB – Get Rating) and Alpha Pro Tech (NYSE:APT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

0.4% of Nutriband shares are held by institutional investors. Comparatively, 27.9% of Alpha Pro Tech shares are held by institutional investors. 42.0% of Nutriband shares are held by insiders. Comparatively, 12.1% of Alpha Pro Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

This table compares Nutriband and Alpha Pro Tech’s net margins, return on equity and return on assets.

Nutriband has a beta of -0.41, meaning that its share price is 141% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -1.12, meaning that its share price is 212% less volatile than the S&P 500.

This table compares Nutriband and Alpha Pro Tech’s gross revenue, earnings per share and valuation.

Alpha Pro Tech has higher revenue and earnings than Nutriband. Nutriband is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

This is a summary of current ratings and target prices for Nutriband and Alpha Pro Tech, as reported by MarketBeat.

Alpha Pro Tech beats Nutriband on 7 of the 10 factors compared between the two stocks.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops products in pipeline, such as AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

About Alpha Pro Tech (Get Rating)

Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, and synthetic roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.

Financial Review: FIGS (FIGS) & Its Peers

Head to Head Analysis: Owlet (OWLT) & Its Rivals